KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Restructuring Costs (2016 - 2024)

Bausch Health Companies (BHC) has disclosed Restructuring Costs for 16 consecutive years, with -$2.0 million as the latest value for Q4 2024.

  • Quarterly Restructuring Costs rose 33.33% to -$2.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Sep 2024, down 116.67% year-over-year, with the annual reading at $33.0 million for FY2022, 3.12% up from the prior year.
  • Restructuring Costs hit -$2.0 million in Q4 2024 for Bausch Health Companies, down from $2.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $13.0 million in Q2 2022 to a low of -$3.0 million in Q4 2023.
  • Historically, Restructuring Costs has averaged $5.4 million across 5 years, with a median of $5.0 million in 2021.
  • Biggest five-year swings in Restructuring Costs: surged 233.33% in 2020 and later tumbled 200.0% in 2023.
  • Year by year, Restructuring Costs stood at $10.0 million in 2020, then rose by 20.0% to $12.0 million in 2021, then plummeted by 75.0% to $3.0 million in 2022, then crashed by 200.0% to -$3.0 million in 2023, then skyrocketed by 33.33% to -$2.0 million in 2024.
  • Business Quant data shows Restructuring Costs for BHC at -$2.0 million in Q4 2024, $2.0 million in Q3 2024, and -$3.0 million in Q4 2023.